| |
Entry in care
|
Retention in care
|
|---|
|
Characteristic
|
Entry
|
OR for no entry (95 % CI)
|
AORa for no entry (95 % CI)
|
Retained
|
OR for no retention (95 % CI)
|
AORa for no retention (95 % CI)
|
|---|
|
Sex
| | | | | | |
|
Male
|
88.8 %
|
1
|
1
|
92.9 %
|
1
|
1
|
|
Female
|
83.9 %
|
1.52 (1.26–1.83)
|
0.83 (0.58–1.19)
|
91.0 %
|
1.30 (1.13–1.49)
|
0.82 (0.66–1.04)
|
|
Age at diagnosis
| | | | | | |
|
<40 years
|
87.1 %
|
1
|
1
|
94.1 %
|
1
|
1
|
|
≥40 years
|
87.0 %
|
1.01 (0.84–1.22)
|
0.91 (0.67–1.24)
|
93.9 %
|
1.02 (0.86–1.23)
|
1.01 (0.81–1.25)
|
|
Way of transmission
| | | | | | |
|
Heterosexual
|
91.4 %
|
1
|
1
|
91.8 %
|
1
|
1
|
|
MSM
|
94.6 %
|
0.61 (0.45–0.82)
|
0.97 (0.62–1.51)
|
95.1 %
|
0.56 (0.45–0.70)
|
0.59 (0.45–0.78)
|
|
IDU
|
85.7 %
|
1.77 (0.85–3.66)
|
1.69 (0.71–4.05)
|
85.8 %
|
1.87 (1.22–2.86)
|
2.01 (1.27–3.17)
|
|
Nationality
| | | | | | |
|
Belgian
|
95.7 %
|
1
|
1
|
95.8 %
|
1
|
1
|
|
SSA
|
88.8 %
|
2.82 (2.05–3.88)
|
3.36 (2.14–5.27)
|
92.8 %
|
1.74 (1.42–2.12)
|
1.50 (1.16–1.93)
|
|
European
|
88.5 %
|
2.91 (1.94–4.35)
|
2.43 (1.52–3.90)
|
91.7 %
|
2.03 (1.48–2.78)
|
1.88 (1.35–2.61)
|
|
Other
|
88.0 %
|
3.04 (1.93–4.79)
|
3.01 (1.81–5.01)
|
93.4 %
|
1.58 (1.09–2.29)
|
1.43 (0.97–2.10)
|
|
Reason for testing
| | | | | | |
|
Patient’s request
|
93.3 %
|
1
|
1
|
95.0 %
|
1
|
1
|
|
Clinical arguments
|
93.5 %
|
0.97 (0.69–1.36)
|
0.90 (0.61–1.32)
|
94.3 %
|
1.15 (0.88–1.50)
|
1.01 (0.77–1.34)
|
|
Preoperative
|
79.2 %
|
3.68 (2.01–6.73)
|
3.91 (2.03–7.53)
|
93.1 %
|
1.42 (0.82–2.46)
|
1.31 (0.74–2.32)
|
|
Other
|
90.3 %
|
1.51 (1.04–2.20)
|
0.98 (0.63–1.53)
|
92.9 %
|
1.46 (1.09–1.95)
|
1.20 (0.89–1.63)
|
|
CD4 at first visit
| | | | | | |
|
CD4≥350
|
/
|
/
|
/
|
93.2 %
|
1
|
1
|
|
CD4≥200 & <350
|
/
|
/
|
/
|
91.3 %
|
1.30 (0.90–1.86)
|
1.12 (0.74–1.69)
|
|
CD4 < 200
|
/
|
/
|
/
|
91.5 %
|
1.28 (0.87–1.86)
|
1.16 (0.76–1.77)
|
|
Time since HIV diagnosis
| | | | | |
|
<1 year
|
/
|
/
|
/
|
90.0 %
|
1
|
1
|
|
1 – <5 years
|
/
|
/
|
/
|
93.9 %
|
0.59 (0.47–0.74)
|
0.55 (0.42–0.72)
|
|
5 – <10 years
|
/
|
/
|
/
|
95.4 %
|
0.44 (0.34–0.56)
|
0.42 (0.32–0.56)
|
|
≥10 years
|
/
|
/
|
/
|
95.7 %
|
0.41 (0.32–0.51)
|
0.40 (0.31–0.53)
|
|
ART
| | | | | | |
|
Not on ART end 2009
|
/
|
/
|
/
|
93.5 %
|
1
|
1
|
|
On ART end 2009
|
/
|
/
|
/
|
96.6 %
|
0.50 (0.39–0.64)
|
0.45 (0.34–0.61)
|
- p < 0.05, statistically significant variables presented in boldface
- aAdjusted for sex, age at diagnosis, nationality, way of transmission
